Evidence map›Paper›PMID 36381422›Full record

ArticleInternational journal of clinical and experimental pathology2022

Role of macrophages in progression of colorectal cancer: a contrast with the traditional paradigm.

Aleksei S Konstantinov, Olga V Kovaleva, Daria V Samoilova, Ksenya V Shelekhova

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aleksei S KonstantinovDepartment of Pathology, St. Petersburg Clinical Research and Practical Center for Specialized Oncological Care St. Petersburg, Russia.
Olga V KovalevaN.N. Blokhin Russian Cancer Research Center Moscow, Russia.
Daria V SamoilovaN.N. Blokhin Russian Cancer Research Center Moscow, Russia.
Ksenya V ShelekhovaDepartment of Pathology, St. Petersburg Clinical Research and Practical Center for Specialized Oncological Care St. Petersburg, Russia.
Russian Cancer Research Center NN Blokhin · RUSaint-Petersburg Medico-Social Institute · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The phenotype of tumor-associated macrophages may be critical for tumor immunity, angiogenesis, and clinical disease outcome. Here, we elucidated the prognostic significance of the neovasculature and macrophages in colorectal cancer. We analyzed the effect of M2 macrophage density on the clinical behavior of 151 primary colorectal carcinomas using CD206 as a marker for type 2 macrophages. Triple immunohistochemical staining (ERG, SMA, and podoplanin) was used for microvessel evaluation. We found that M2 macrophages in colorectal cancer did not have a direct association with metastatic behavior. However, high numbers of CD206 tumor-associated macrophages correlated positively with recurrence-free interval duration (P=0.005). Fewer macrophages in the tumor microenvironment resulted in insufficient coverage of newly formed vessels by pericytes (P=0.011), and a high number of pericyte-impaired microvessels correlated with metastatic behavior (P<0.001). These results suggested that type 2 macrophages had a role in limiting the metastatic process by affecting vascular maturity and normalization. These findings contribute to understanding complex interactions in the tumor microenvironment and the clinical behavior of colorectal cancer.

Indexed as

alternatively activated macrophagesangiogenesisColorectal cancerM2prognosistumor microenvironment

Identifiers

PMID36381422
PMCPMC9638838
OpenAlexW4309242689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.